glp-1 drugs and lupus Can GLP-1's Be Used to Treat in Patients with Diabetes? A Closer Look at the
Description
For the comparator drugs, event rates between 0.7 and 3.1 per 1,000 patient-years were calculated
Mounjaro (tirzepatide) Mounjaro is a GLP-1 agonist with the active ingredient tirzepatide
Insulin receptor in the brain: Mechanisms of activation and the role in the CNS pathology and treatment
326 , F545f559 (2024)
As a result, GLP-1 receptor agonists can be utilized to treat diabetes
Am J Physiol Metab
